For the year ending 2025-12-31, MCRB made $789K in revenue. $5,696K in net income. Net profit margin of 721.93%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 789 | |||
| Research and development expenses | 49,060 | |||
| General and administrative expenses | 39,156 | |||
| Manufacturing services | 6,544 | |||
| Total operating expenses | 94,760 | |||
| Loss from operations | -93,971 | |||
| Gain on sale of vowst business | 80,685 | |||
| Interest income | 2,227 | |||
| Interest expense | 0 | |||
| Other income (expense), net | 16,755 | |||
| Total other income (expense), net | 99,667 | |||
| Net income (loss) from continuing operations | 5,696 | |||
| Total revenue | 0 | |||
| Research and development expenses | 0 | |||
| General and administrative expenses | 0 | |||
| Collaboration (profit) loss sharing - related party | 0 | |||
| Total operating expenses | 0 | |||
| (loss) income from discontinued operations | 0 | |||
| Gain on sale of vowst business | 0 | |||
| Interest expense | 0 | |||
| Other expense | 0 | |||
| Income (loss) from discontinued operations, pre-tax | 0 | |||
| Income tax | 0 | |||
| Net income from discontinued operations, net of tax | 0 | |||
| Net income (loss) | 5,696 | |||
| Unrealized gain on investments, net of tax of 0 | 0 | |||
| Currency translation adjustment | 0 | |||
| Total other comprehensive income | 0 | |||
| Comprehensive income (loss) | 5,696 | |||
| Basic EPS | 0.64 | |||
| Diluted EPS | 0.64 | |||
| Basic Average Shares | 8,858,975 | |||
| Diluted Average Shares | 8,869,742 | |||
Seres Therapeutics, Inc. (MCRB)
Seres Therapeutics, Inc. (MCRB)